Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Oral Palifosfamide Tris in Advanced, Refractory, Solid Tumors

NCT00607711 is registered in ClinicalTrials.gov with Alaunos Therapeutics as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00607711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Oral Palifosfamide Tris in Advanced, Refractory, Solid Tumors
Lead sponsor
Alaunos Therapeutics
Phase
Phase 1
Overall status
Withdrawn
Start date
March 31, 2008
Completion date
November 30, 2009
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer